1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018).

2. Bianconi, E., Piovesan, A., Facchin, F., Beraudi, A., Casadei, R., Frabetti, F. et al. An estimation of the number of cells in the human body. Ann. Hum. Biol. 40, 463–471 (2013).

3. Caspari, R. & Lee, S. H. Older age becomes common late in human evolution. Proc. Natl Acad. Sci. USA 101, 10895–10900 (2004).

4. Kaplan, H., Hill, K., Lancaster, J. & Hurtado, A. M. A theory of human life history evolution: diet, intelligence, and longevity. Evol. Anthropol. 9, 156–185 (2000).

5. Medawar, P. An Unsolved Problem of Biology (H.K.Lewis, London, 1952).

6. Williams, G. C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 11, 398–411 (1957).

7. Kirkwood, T. B. Understanding the odd science of aging. Cell 120, 437–447 (2005).

8. Hamilton, W. D. The moulding of senescence by natural selection. J. Theor. Biol. 12, 12–45 (1966).

9. Tomasetti, C., Li, L. & Vogelstein, B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355, 1330–1334 (2017).

10. Tomasetti, C. & Vogelstein, B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78–81 (2015).

11. Wu, S., Powers, S., Zhu, W. & Hannun, Y. A. Substantial contribution of extrinsic risk factors to cancer development. Nature 529, 43–47 (2016).

12. DeGregori, J. Connecting cancer to its causes requires incorporation of effects on tissue microenvironments. Cancer Res. 77, 6065–6068 (2017).

13. Ward, P. D. & Kirschvink, J. L. A New History of Life: The Radical New Discoveries About the Origins and Evolution of Life on Earth (Bloomsbury Press, New York, 2015).

14. Eldredge, N. The Pattern of Evolution (W.H. Freeman, New York, 1999).

15. Eldredge, N. & Gould, S. J. On punctuated equilibria. Science 276, 338–341 (1997).

16. Angelidis, I., Simon, L. M., Fernandez, I. E., Strunz, M., Mayr, C. H., Greiffo, F. R. et al. An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics. Nat. Commun. 10, 963 (2019).

17. Phillip, J. M., Aifuwa, I., Walston, J. & Wirtz, D. The mechanobiology of aging. Annu. Rev. Biomed. Eng. 17, 113–141 (2015).

18. Rozhok, A. & DeGregori, J. A generalized theory of age-dependent carcinogenesis. eLife 8, e39950 (2019).

19. CRUK. Cancer Incidence by Age. Cancer Research UK (CRUK) http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/age#heading-Zero.

20. Epstein, M. & Hollenberg, N. K. Age as a determinant of renal sodium conservation in normal man. J. Lab. Clin. Med. 87, 411–417 (1976).

21. Finegold, J. A., Asaria, P. & Francis, D. P. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int. J. Cardiol. 168, 934–945 (2013).

22. Samet, J. M., Avila-Tang, E., Boffetta, P., Hannan, L. M., Olivo-Marston, S., Thun, M. J. et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin. Cancer Res. 15, 5626–5645 (2009).

23. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 9 Regs Research Data, 1973–2012 November 2014 Submission http://www.seer.cancer.gov (2014).

24. Marongiu, F., Serra, M. P., Sini, M., Angius, F. & Laconi, E. Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma. Aging (Albany, NY) 6, 26–34 (2014).

25. Pasciu, D., Montisci, S., Greco, M., Doratiotto, S., Pitzalis, S., Pani, P. et al. Aging is associated with increased clonogenic potential in rat liver in vivo. Aging Cell 5, 373–377 (2006).

26. Layde, P. M., Webster, L. A., Baughman, A. L., Wingo, P. A., Rubin, G. L. & Ory, H. W. The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. J. Clin. Epidemiol. 42, 963–973 (1989).

27. Strassmann, B. I. Menstrual cycling and breast cancer: an evolutionary perspective. J. Womens Health 8, 193–202 (1999).

28. Pomatto, L. C. D., Sun, P. Y. & Davies, K. J. A. To adapt or not to adapt: consequences of declining adaptive homeostasis and proteostasis with age. Mech. Ageing Dev. 177, 80–87 (2019).

29. Hochberg, M. E. & Noble, R. J. A framework for how environment contributes to cancer risk. Ecol. Lett. 20, 117–134 (2017).

30. Madeo, F., Zimmermann, A., Maiuri, M. C. & Kroemer, G. Essential role for autophagy in life span extension. J. Clin. Invest. 125, 85–93 (2015).

31. Fernández, Á. F., Sebti, S., Wei, Y., Zou, Z., Shi, M., McMillan, K. L. et al. Disruption of the beclin 1–BCL2 autophagy regulatory complex promotes longevity in mice. Nature 558, 136–140 (2018).

32. Pyo, J. O., Yoo, S. M., Ahn, H. H., Nah, J., Hong, S. H., Kam, T. I. et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat. Commun. 4, 2300 (2013).

33. Vijg, J. Somatic mutations, genome mosaicism, cancer and aging. Curr. Opin. Genet. Dev. 26C, 141–149 (2014).

34. Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J. & van Deursen, J. M. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 15, 1139–1153 (2014).

35. Georgakopoulou, E., Evangelou, K., Havaki, S., Townsend, P., Kanavaros, P. & Gorgoulis, V. G. Apoptosis or senescence? Which exit route do epithelial cells and fibroblasts preferentially follow? Mech. Ageing Dev. 156, 17–24 (2016).

36. Kamijo, T., Bodner, S., van de Kamp, E., Randle, D. H. & Sherr, C. J. Tumor spectrum in ARF-deficient mice. Cancer Res. 59, 2217–2222 (1999).

37. Sharpless, N. E., Bardeesy, N., Lee, K. H., Carrasco, D., Castrillon, D. H., Aguirre, A. J. et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413, 86–91 (2001).

38. Ritschka, B., Storer, M., Mas, A., Heinzmann, F., Ortells, M. C., Morton, J. P. et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 31, 172–183 (2017).

39. Tauber, A. I. Reconceiving autoimmunity: an overview. J. Theor. Biol. 375, 52–60 (2015).

40. Pradeu, T. & Vivier, E. The discontinuity theory of immunity. Sci. Immunol. 1, AAG0479 (2016).

41. Sagiv, A., Burton, D. G., Moshayev, Z., Vadai, E., Wensveen, F., Ben-Dor, S. et al. NKG2D ligands mediate immunosurveillance of senescent cells. Aging 8, 328–344 (2016).

42. Kang, T. W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547–551 (2011).

43. Ogrodnik, M., Salmonowicz, H. & Gladyshev, V. N. Integrating cellular senescence with the concept of damage accumulation in aging: relevance for clearance of senescent cells. Aging Cell 18, e12841 (2019).

44. Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J. et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature 530, 184 (2016).

45. Siegel, J. J. & Amon, A. New insights into the troubles of aneuploidy. Annu. Rev. Cell Dev. Biol. 28, 189–214 (2012).

46. Pfau, S. J., Silberman, R. E., Knouse, K. A. & Amon, A. Aneuploidy impairs hematopoietic stem cell fitness and is selected against in regenerating tissues in vivo. Genes Dev. 30, 1395–1408 (2016).

47. Bolton, H., Graham, S. J. L., Van der Aa, N., Kumar, P., Theunis, K., Fernandez Gallardo, E. et al. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nat. Commun. 7, 11165 (2016).

48. DeGregori, J. Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res. 71, 3739–3744 (2011).

49. Mittal, D., Gubin, M. M., Schreiber, R. D. & Smyth, M. J. New insights into cancer immunoediting and its three component phases-elimination, equilibrium and escape. Curr. Opin. Immunol. 27, 16–25 (2014).

50. Morata, G. & Ripoll, P. Minutes: mutants of Drosophila autonomously affecting cell division rate. Dev. Biol. 42, 211–221 (1975).

51. Madan, E., Gogna, R. & Moreno, E. Cell competition in development: information from flies and vertebrates. Curr. Opin. Cell Biol. 55, 150–157 (2018).

52. Amoyel, M. & Bach, E. A. Cell competition: how to eliminate your neighbours. Development 141, 988–1000 (2014).

53. Bowling, S., Lawlor, K. & Rodriguez, T. A. Cell competition: the winners and losers of fitness selection. Development 146, dev167486 (2019).

54. Merino Marisa, M., Rhiner, C., Lopez-Gay Jesus, M., Buechel, D., Hauert, B. & Moreno, E. Elimination of unfit cells maintains tissue health and prolongs lifespan. Cell 160, 461–476 (2015).

55. Morata, G. & Calleja, M. Cell competition and tumorigenesis in the imaginal discs of Drosophila. Semin. Cancer Biol. https://doi.org/10.1016/j.semcancer.2019.06.010 (2019).

56. Kajita, M. & Fujita, Y. EDAC: Epithelial defence against cancer-cell competition between normal and transformed epithelial cells in mammals. J. Biochem. 158, 15–23 (2015).

57. Brown, S., Pineda, C. M., Xin, T., Boucher, J., Suozzi, K. C., Park, S. et al. Correction of aberrant growth preserves tissue homeostasis. Nature 548, 334–337 (2017).

58. Sasaki, A., Nagatake, T., Egami, R., Gu, G., Takigawa, I., Ikeda, W. et al. Obesity suppresses cell-competition-mediated apical elimination of RasV12-transformed cells from epithelial tissues. Cell Rep. 23, 974–982 (2018).

59. Ellis, S. J., Gomez, N. C., Levorse, J., Mertz, A. F., Ge, Y. & Fuchs, E. Distinct modes of cell competition shape mammalian tissue morphogenesis. Nature 569, 497–502 (2019).

60. Liu, N., Matsumura, H., Kato, T., Ichinose, S., Takada, A., Namiki, T. et al. Stem cell competition orchestrates skin homeostasis and ageing. Nature 568, 344–350 (2019).

61. Boss, G. R. & Seegmiller, J. E. Age-related physiological changes and their clinical significance. West J. Med. 135, 434–440 (1981).

62. Sas, A. A., Snieder, H. & Korf, J. Gompertz' survivorship law as an intrinsic principle of aging. Med. Hypotheses 78, 659–663 (2012).

63. Koopman, J. J., van Heemst, D., van Bodegom, D., Bonkowski, M. S., Sun, L. Y. & Bartke, A. Measuring aging rates of mice subjected to caloric restriction and genetic disruption of growth hormone signaling. Aging 8, 539–546 (2016).

64. Rozhok, A. I. & DeGregori, J. Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations. Proc. Natl Acad. Sci. USA 112, 8914–8921 (2015).

65. DeGregori, J. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age? Oncogene 32, 1869–1875 (2013).

66. Laconi, E. The evolving concept of tumor microenvironments. Bioessays 29, 738–744 (2007).

67. Henry, C. J., Casas-Selves, M., Kim, J., Zaberezhnyy, V., Aghili, L., Daniel, A. E. et al. Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. J. Clin. Invest. 125, 4666–4680 (2015).

68. Henry, C. J., Marusyk, A., Zaberezhnyy, V., Adane, B. & DeGregori, J. Declining lymphoid progenitor fitness promotes aging-associated leukemogenesis. Proc. Natl Acad. Sci. USA 107, 21713–21718 (2010).

69. Vas, V., Wandhoff, C., Dorr, K., Niebel, A. & Geiger, H. Contribution of an aged microenvironment to aging-associated myeloproliferative disease. PLoS ONE 7, e31523 (2012).

70. Parikh, N., Shuck, R. L., Gagea, M., Shen, L. & Donehower, L. A. Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice. Aging Cell https://doi.org/10.1111/acel.12691 (2017).

71. Marongiu, F., Serra, M. P., Doratiotto, S., Sini, M., Fanti, M., Cadoni, E. et al. Aging promotes neoplastic disease through effects on the tissue microenvironment. Aging 8, 3390–3399 (2016).

72. McCullough, K. D., Coleman, W. B., Ricketts, S. L., Wilson, J. W., Smith, G. J. & Grisham, J. W. Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc. Natl Acad. Sci. USA 95, 15333–15338 (1998).

73. Cadoni, E., Marongiu, F., Fanti, M., Serra, M. & Laconi, E. Caloric restriction delays early phases of carcinogenesis via effects on the tissue microenvironment. Oncotarget 8, 36020–36032 (2017).

74. Serra, M., Marongiu, F., Pisu, M. G., Serra, M. & Laconi, E. Time-restricted feeding delays the emergence of the age-associated, neoplastic-prone tissue landscape. Aging 11, 3851–3863 (2019).

75. Marusyk, A. & DeGregori, J. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim. Biophys. Acta 1785, 1–11 (2008).

76. Serra, M. P., Marongiu, F., Marongiu, M., Contini, A. & Laconi, E. Cell-autonomous decrease in proliferative competitiveness of the aged hepatocyte. J. Hepatol. 62, 1341–1348 (2015).

77. Fleenor, C. J., Rozhok, A. I., Zaberezhnyy, V., Mathew, D., Kim, J., Tan, A. C. et al. Contrasting roles for C/EBPalpha and Notch in irradiation-induced multipotent hematopoietic progenitor cell defects. Stem Cells 33, 1345–1358 (2015).

78. Fernandez-Antoran, D., Piedrafita, G., Murai, K., Ong, S. H., Herms, A., Frezza, C. et al. Outcompeting p53-mutant cells in the normal esophagus by redox manipulation. Cell Stem Cell. 25, 329.e6–341.e6 (2019).

79. Zhang, W., Hanks, A. N., Boucher, K., Florell, S. R., Allen, S. M., Alexander, A. et al. UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis 26, 249–257 (2005).

80. Lee, C. L., Castle, K. D., Moding, E. J., Blum, J. M., Williams, N., Luo, L. et al. Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma. Nat. Commun. 6, 8477 (2015).

81. Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014).

82. Winawer, S. J., Zauber, A. G., Gerdes, H., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S. et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N. Engl. J. Med. 334, 82–87 (1996).

83. Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S. et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).

84. Martincorena, I., Fowler, J. C., Wabik, A., Lawson, A. R. J., Abascal, F., Hall, M. W. J. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911–917 (2018).

85. Yokoyama, A., Kakiuchi, N., Yoshizato, T., Nannya, Y., Suzuki, H., Takeuchi, Y. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312–317 (2019).

86. McKerrell, T., Park, N., Moreno, T., Grove Carolyn, S., Ponstingl, H., Stephens, J. et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 10, 1239–45 (2015).

87. Genovese, G., Kahler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014).

88. Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472–1478 (2014).

89. Busque, L., Patel, J. P., Figueroa, M. E., Vasanthakumar, A., Provost, S., Hamilou, Z. et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat. Genet. 44, 1179–1181 (2012).

90. Salk, J. J., Loubet-Senear, K., Maritschnegg, E., Valentine, C. C., Williams, L. N., Higgins, J. E. et al. Ultra-sensitive TP53 sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan. Cell Rep. 28, 132–144.e3 (2019).

91. Martincorena, I. Somatic mutation and clonal expansions in human tissues. Genome Med. 11, 35 (2019).

92. Risques, R. A. & Kennedy, S. R. Aging and the rise of somatic cancer-associated mutations in normal tissues. PLoS Genet. 14, e1007108 (2018).

93. Martincorena, I., Fowler, J. C., Wabik, A., Lawson, A. R. J., Abascal, F., Hall, M. W. J. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911–917 (2018).

94. Simons, B. D. Deep sequencing as a probe of normal stem cell fate and preneoplasia in human epidermis. Proc. Natl Acad. Sci. USA 113, 128–133 (2016).

95. Young, A. L., Challen, G. A., Birmann, B. M. & Druley, T. E. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat. Commun. 7, 12484 (2016).

96. Jonason, A. S., Kunala, S., Price, G. J., Restifo, R. J., Spinelli, H. M., Persing, J. A. et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA 93, 14025–14029 (1996).

97. Bowman, R. L., Busque, L. & Levine, R. L. Clonal hematopoiesis and evolution to hematopoietic malignancies. Cell Stem Cell 22, 157–170 (2018).

98. Coombs, C. C., Zehir, A., Devlin, S. M., Kishtagari, A., Syed, A., Jonsson, P. et al. Therapy-Related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374.e4–382.e4 (2017).

99. Kahn, J. D., Miller, P. G., Silver, A. J., Sellar, R. S., Bhatt, S., Gibson, C. et al. PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood 132, 1095–1105 (2018).

100. Hsu, J. I., Dayaram, T., Tovy, A., De Braekeleer, E., Jeong, M., Wang, F. et al. PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell 23, 700–13.e6. (2018).

101. Takahashi, K., Wang, F., Kantarjian, H., Doss, D., Khanna, K., Thompson, E. et al. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. Lancet Oncol. 18, 100–111 (2017).

102. Gillis, N. K., Ball, M., Zhang, Q., Ma, Z., Zhao, Y., Yoder, S. J. et al. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. Lancet Oncol. 18, 112–121 (2017).

103. Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E. et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559, 400–404 (2018).

104. Higa, K. C. & DeGregori, J. Decoy fitness peaks, tumor suppression, and aging. Aging Cell 18, e12938 (2019).

105. Zhu, M., Lu, T., Jia, Y., Luo, X., Gopal, P., Li, L. et al. Somatic mutations increase hepatic clonal fitness and regeneration in chronic liver disease. Cell 177, 608.e12–621.e12 (2019).

106. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).

107. Kaeberlein, M. & Galvan, V. Rapamycin and Alzheimer's disease: time for a clinical trial? Sci. Transl. Med. 11, eaar4289 (2019).

108. Glossmann, H. H. & Lutz, O. M. D. Metformin and aging: a review. Gerontology 65, 581–590 (2019).

109. Short, S., Fielder, E., Miwa, S. & von Zglinicki, T. Senolytics and senostatics as adjuvant tumour therapy. EBioMedicine 41, 683–692 (2019).

110. Matai, L., Sarkar, G. C., Chamoli, M., Malik, Y., Kumar, S. S., Rautela, U. et al. Dietary restriction improves proteostasis and increases life span through endoplasmic reticulum hormesis. Proc. Natl Acad. Sci. USA 116, 17383–17392 (2019).

111. Escobar, K. A., Cole, N. H., Mermier, C. M. & VanDusseldorp, T. A. Autophagy and aging: maintaining the proteome through exercise and caloric restriction. Aging Cell 0, e12876 (2018).

112. Mercken, E. M., Carboneau, B. A., Krzysik-Walker, S. M. & de Cabo, R. Of mice and men: the benefits of caloric restriction, exercise, and mimetics. Ageing Res. Rev. 11, 390–398 (2012).

113. Todoric, J., Antonucci, L. & Karin, M. Targeting inflammation in cancer prevention and therapy. Cancer Prev. Res. (Phila.) 9, 895–905 (2016).

114. Zhang, J., Cunningham, J. J., Brown, J. S. & Gatenby, R. A. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nat. Commun. 8, 1816 (2017).